The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

Key Takeaways U.S. health agencies are investigating possible side effects of a chikungunya vaccineOlder adults, especially ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

Under Robert F. Kennedy Jr, the FDA has purged public health information on vaccines, contraception, HIV, and more. Internal ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.